Elisabetta Argenzio, Ph.D.
Editor, EMBO J
Elisabetta received her PhD from the European School of Molecular Medicine (SEMM) in Milan where she studied the role of ubiquitination in EGF receptor signalling and endocytosis in the labs of Simona Polo and Pier Paolo Di Fiore. In 2009, she joined Wouter Moolenaar’s group at The Netherlands Cancer Institute in Amsterdam for her post-doctoral work on the regulation of integrin trafficking and signalling by lipid grow factors and intracellular chloride channels. Subsequently, she got interested in translational cancer research and, as senior postdoctoral fellow in the laboratory of Marcel Verheij at the same institute, she characterised the uptake mechanisms of alkyl-lysophospholipid drugs. Elisabetta joined The EMBO Journal in 2017 where she is responsible for the areas of membranes & intracellular transport and cell death & autophagy.
John F. Foley, Ph.D.,
Editor, Science Signaling
John received his B.Sc. and Ph.D. in the Department of Biochemistry, University College, Dublin, Ireland, where he studied the G protein usage and mechanisms of regulation of members of a family of G protein–coupled receptors (GPCRs) known as prostanoid receptors in the cardiovascular system. He continued in the GPCR field, this time in an immunological context, by studying chemokine receptor function and regulation in leukocytes in postdoctoral positions at the National Institutes of Health. In 2007, John joined Science’s STKE (Signal Transduction Knowledge Environment) as an Associate Editor. The journal name was changed to Science Signaling in 2008, when its scope was broadened to include primary research papers. John has served as the Editor of Science Signaling since June 2017 and continues to be the primary editor responsible for manuscripts in the areas of biochemistry and GPCR signaling, among others.